Home » Tenders » Americas » USA » Tender 146356564

Presolicitation Notice Barda Vaccine Medical Tender - 146356564

The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE has issued a Tender notice for the procurement of a Presolicitation Notice Barda Vaccine Medical Countermeasures for Pandemic Influenza Preparedness Response in the USA. This Tender notice was published on 01 Aug 2026 and is scheduled to close on 15 Aug 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 146356564, while the tender notice number is and Registering on the platform.

Procurement Summary

Country: USA

Summary: Presolicitation Notice Barda Vaccine Medical Countermeasures for Pandemic Influenza Preparedness Response

Deadline: 15 Aug 2026

Posting Date: 01 Aug 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 146356564

Document Ref. No.:

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Tender Details

Description:
BARDA seeks Contractor(s) to support the continuation of the Vaccine MCMs for Pandemic Influenza Preparedness and Response Program. Contractors will furnish all the necessary services, qualified personnel, materials, supplies, equipment and facilities (U.S. facilities preferred) not otherwise provided by the USG as needed to provide MCMs, such as vaccines, antigens, and adjuvants, for pandemic preparedness and response or as required in response to a public health emergency; produce antigen and vaccines against influenza virus or other viruses with pandemic potential as required by BARDA; produce antigens, adjuvants, and/or vaccines to support USG efforts to further improve influenza vaccines (for which feasibility data is available); and support rapid regulatory decisions and manufacturing readiness by generating and submitting to FDA all relevant data (e.g., analytical, nonclinical, clinical, and/or chemistry, manufacturing, and controls (CMC)), including data generated during interpandemic periods.
Mandatory Qualification Requirements:
To be eligible for award, the Offeror must produce vaccines against influenza and influenza strains with pandemic potential; must demonstrate a successful experience in the manufacturing of influenza vaccine by:
Holding a U.S. influenza vaccine license; or
Have developed an influenza vaccine as evidenced by: a.Submission of a BLA for seasonal or pandemic influenza vaccine
Please see attachment to this presolicitation notice for further important information.
Notice ID: 75a50126r00001_rfp_presolnotice_npivs-2027

Department/Ind. Agency: health and human services, department of

Sub-tier: office of assistant secretary for preparedness and response

Office: barda - aspr / daappo / barda dcma

Product Service Code: an12 - health r&d services; health care services; applied research

NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Inactive Dates: aug 30, 2026

Inactive Policy: 15 days after response date

Documents

Browse More

All Tenders From Americas

Procurement Documents for USA

Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA

Explore Procurement Documents for USA

Want To Bid in This Tender?

Get Local Agent Support in USA and 60 More Countries.

View All The Services

View Tenders By